The latest advances from BioVentures for Global Health in Africa
Published: 5 Jun 2019
Views: 1065
Jennifer Dent - BioVentures for Global Health, Seattle, USA
Jennifer Dent speaks to ecancer at the Global Health Catalyst Summit 2019 at the Dana Farber Cancer Institute in Boston, Massachusetts about the progress of BioVentures for Global Health since her last interview at AACR in April.
She outlines three of the current projects from BioVentures, including improving access in Nigeria, capacity building in Côte d'Ivoire, and launching new work in Senegal.
Jennifer also describes some of the main reasons we need to build capacity and access in these areas, and how momentum is building in this promising field.
Related Videos
Breast Cancer at ASCO 2020 - AORTIC African Cancer Dialogues
Host: Dr. Miriam Mutebi, Speakers: Dr. Verna Vanderpuye, Dr. Sitna Mwanzi
6 Aug 2020
The European Cancer Prevention Organization
Prof. Jaak Janssens - Hasselt, Belgium
22 Jul 2020
Meet the Expert: Prof Ifeoma Okoye
Prof Ifeoma Okoye - University of Nigeria, Nsukka, Nigeria
1 May 2020
Cancer care in low and middle income countries
Dr Gouri Bhattacharyya - FORTIS Hospital, Kolkata, India
12 Jul 2019
Challenges in global cancer control
Prof Mary Gospodarowicz
12 Jul 2019
Implementing national cancer control plans
Dr Lisa Stevens, Dr Eduardo Cazap
12 Jul 2019
How will ASCO combat cancer disparities?
Dr Richard Schilsky and Dr Eduardo Cazap
12 Jul 2019
Prof Ahmed Elzawawy on global cancer control
Prof Ahmed Elzawawy, Dr Eduardo Cazap
12 Jul 2019
The global program of the American Cancer Society
Dr Meg O'Brien - American Cancer Society, Atlanta, USA
5 Jun 2019
